Pancreatic Cancer Research

ResearcherMersin ÜniversitesiActive in the last 2 years

Ahmet Ata Özçimen

ORCID-verified (high confidence)As of 11 November 2026

Matched on ORCID iD 0000-0002-8871-8943; OpenAlex author ID A5025745892.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 3

  1. Anti-cancer effect of vitexin onto the CFPAC-1 and MIAPaCa-2 pancreatic cancer cells. Co-author DOI 10.1007/s10616-026-01079-4↗
  2. The Supression of Migration and Metastasis via Inhibition of Vascular Endothelial Growth Factor in Pancreatic Adenocarcinoma Cells Applied Danusertib. Last author DOI 10.5152/tjg.2024.22319↗
  3. The effect of danusertib, an Aurora kinase inhibitor, onto the cytotoxicity, cell cycle and apoptosis in pancreatic ductal adenocarcinoma cells. Last author DOI 10.4103/jcrt.jcrt_827_19↗

Closest collaborators

The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Hatice Oruç Demirbağ · 1 shared paper, 2026
  2. Yaşar Kevser · 1 shared paper, 2026
  3. Erkan Alabaş · 1 shared paper, 2024
  4. Ismail Ayberk Kirbiyik · 1 shared paper, 2021

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.